Month: February 2020

During the twelve months of 2019, AUGA group, AB and its subsidiaries’ (hereinafter – the Group) results showed improvement in all the business segments.Sales revenue amounted to EUR 71.13 million, demonstrating an  increase of 30% compared to the same period in 2018, when it totalled EUR 54.75 million.The Group’s gross profit for year of 2019 amounted to EUR 11.92 million and showed  186% growth or was EUR 6.81 million higher, compared to the same period in 2018 (gross profit for year 2018 was EUR 3.66 million).Per twelve months period of 2019, Group’s net loss amounted to EUR 2.44 compared to net loss of EUR 5.98 million a year earlier. It should be noted that the financial results of both 2019 and 2018 were highly affected  by several one-off events and changes in accounting standards and policies. These  are discussed in the...

Per 2019 m. „AUGA group“, AB ir jos dukterinių bendrovių (toliau – Grupė) rezultatai  ženkliai pagerėjo visuose Grupės veiklos segmentuose.Bendrosios pardavimo pajamos siekė 71,13 mln. Eur ir buvo 30% didesnės nei 2018 m. atitinkamą laikotarpį, kai jos sudarė 54,75 mln. Eur.2019 m. Grupės bendrasis pelnas sudarė 11,92 mln. Eur ir buvo 186% arba 6,81 mln. Eur didesnis nei tuo pačiu laikotarpiu pernai (2018 m. bendrasis pelnas – 3,66 mln. Eur).Per 2019 m. Grupė patyrė 2,44 mln. Eur grynojo nuostolio palyginus su 5,98 mln. Eur nuostolių metais prieš tai. Būtina pažymėti, kad tiek šių metų rezultatams, tiek praėjusių metų atitinkamo laikotarpio rezultatams reikšmingą įtaką turėjo įvairūs vienkartiniai veiksniai bei apskaitos politikos pokyčiai, su kuriais galima susipažinti  pateikiamų tarpinių ataskaitų vadovybės komentare. Eliminavus minėtus...

AUSTIN, TX, Feb. 28, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Bravatek Solutions, Inc. (OTC Pink: BVTK) (“Bravatek” or the “Company”) announced February 27 that it has received a detailed report from its partner, Zoono, that the third party, independent laboratory tests undertaken against COVID-19 showed that Zoono’s Z-71 Microbe Shield (the same Zoono technology used in Zoono hand sanitizer) is > 99.99% effective against COVOID-19. The product sanitizes and kills the virus.COVID-19 has become a global concern, as it has been shown to survive on surfaces for up to nine days. Zoono products have been successfully tested against a variety of pathogens for up to 30 days on surfaces and 24 hours on hands. Bravatek is spearheading the team and will begin immediately providing samples, as well as rigorous test and evaluation results...

Press Release of 28th February 2020 – 20H00In accordance with the AFEP/MEDEF Corporate Governance Code actualized in January 2020 (art. 26.1) HERMES INTERNATIONAL discloses information on all elements, acquired or deferred, of its Executive Chairmen compensation, immediately following the Board meeting having established these elements.PrinciplesArticle 17 of the Articles of Association provides that each Executive Chairman shall be entitled to receive a statutory compensation, and possibly an additional compensation, the maximum amount of which is determined by the Shareholders’ Ordinary General Meeting with the unanimous approval of the active partners. The active partner determines each year the effective compensation of each of the Executive Chairmen within the limits of these ceilings. The active partner relies on the recommendations...

Communiqué du 28 février 2020- 20h00Conformément au Code de gouvernement d’entreprise AFEP / MEDEF actualisé en janvier 2020 (art 26.1) HERMES INTERNATIONAL rend publics tous les éléments de rémunération potentiels ou acquis des gérants immédiatement après la réunion du conseil les ayant arrêtés.PrincipesConformément à l’article 17 des statuts, chaque gérant a droit à une rémunération complémentaire et, éventuellement, à une rémunération statutaire, dont le montant maximal est fixé par l’Assemblée générale ordinaire, avec l’accord unanime des associés commandités. L’associé commandité décide de la rémunération effective de chacun des gérants chaque année dans la limite de ces plafonds. Il s’appuie sur les recommandations du Comité des rémunérations, des nominations, de la gouvernance et de la RSE (« Comité RNG-RSE ») et prend notamment...

PCTI designs, develops and manufactures standard and custom power electronic solutionsWEST PALM BEACH, FL, Feb. 28, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Ozop Surgical Corp. (OTCQB: OZSCD), (“Ozop” or the “Company”), today announces that it has signed a Binding Letter of Intent (the “LOI”) with Power Conversion Technologies, Inc. (“PCTI”), and Catherine Chis (“Chis”), the President of PCTI and its sole shareholder. Pursuant to the terms of the LOI, the Company will acquire 100% of the issued and outstanding common stock of PCTI from Chis. In conjunction with the LOI, Michael Chermak and Barry Hollander resigned as Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), respectively, and Brian Conway was named CEO and Interim CFO. Mr. Chermak remains as the sole Director of the CompanyPCTI operates in the very...

BROOKINGS, S.D., Feb. 28, 2020 (GLOBE NEWSWIRE) — Daktronics (NASDAQ-DAKT) of Brookings, South Dakota, announces it has participated in a Series A investment round in X Display Company (XDC). XDC creates and owns leading intellectual property (IP) and capabilities in microLED mass transfer technology.Series A investments will support XDC’s further development in microLED capabilities and applications. MicroLED technologies support Daktronics’ line of narrow pixel pitch LED displays and will enable solutions to move into the realm of less than 1-millimeter line spacings.“We see a lot of promise in microLEDs and the products we can produce with this technology,” said Daktronics President and CEO Reece Kurtenbach. “We believe XDC is a great partner, with IP and expertise in both the production processes and core technologies needed...

New York, Feb. 28, 2020 (GLOBE NEWSWIRE) —  Interpublic Group (NYSE: IPG) announced today that long-term Acxiom leader Chad Engelgau is being named Chief Executive Officer of the data, technology and marketing services company, which IPG acquired in late 2018. Dennis Self, who has served most recently as CEO, will stay on as an advisor for a period of transition to ensure continuity, before departing for a new venture. Acxiom will continue to report into Arun Kumar, the Chief Data and Technology Officer of IPG. For the past year, Mr. Engelgau has served as the Global Chief Data Strategist at Kinesso, the data intelligence unit that is part of IPG. For the prior thirteen years, Mr. Engelgau held a range of key leadership roles at Acxiom, ultimately overseeing data and identity product development as well as marketing and strategy...

BOTHELL, WA, Feb. 28, 2020 (GLOBE NEWSWIRE) — COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today the closing of its previously announced registered direct offering with several institutional investors for 8,461,540 shares of its common stock at a purchase price of $1.30 per share, priced at-the-market under Nasdaq rules. The gross proceeds to the Company from the offering totaled approximately $11.0 million, before deducting placement agent fees and offering expenses.H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.Cocrystal intends to use the net proceeds for working capital and other general corporate purposes.The shares of common stock described above were offered...

UAB Ignitis Grupė, (hereinafter – the Company) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 600 000 000 EUR; ISIN codes XS1646530565; XS1853999313.Preliminary financial data of Ignitis Group for 1 month of 2020:In January 2020, Ignitis Group generated revenue of EUR 111.5 million, which is 13.2% less compared to a respective period of 2019 (EUR 128.4 million). The Group’s revenue has decreased due to reduced volume of sold gas for business customers which was caused by unusually warm winter and lower gas supply tariffs for household customers.The adjusted EBITDA indicator of the Group in January 2020 was equal to EUR 32.2 million, i.e. 7% more compared to a respective period of 2019 (EUR 30.1 million). The adjusted EBITDA indicator...